STEPHANIE WILLIAMS: Open Payments
NPI 1568816098 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 23 payments from 12 companies in 2025. Trend: 2023 $1,497 · 2024 $952 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 1 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $46 |
| Lilly USA, LLC | 2 | $41 |
| ABBVIE INC. | 2 | $41 |
| Exact Sciences Corporation | 2 | $34 |
| Novo Nordisk Inc | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
Products named: AIRSUPRA, CAPLYTA, REXULTI, AUSTEDO XR, LEQVIO, The Cologuard Plus Collection Kit, UBRELVY, Rybelsus.
Industry payments across TX — which companies pay providers there.
